Psilocybin, the psychoactive compound found in so-called magic mushrooms, has long been studied for the way it transforms perception and mood, but the precise cellular mechanics behind its effects on the brain have remained elusive. A new study led by researchers at the University of California, Santa Cruz, published on October 15 in the journal Nature Neuroscience, now offers a detailed view of how the drug physically reshapes neural connections in living brain tissue. Working in mice, the team demonstrated that psilocybin rapidly accelerates the formation and maturation of new neural connections while simultaneously promoting the elimination of some pre-existing ones.
Perhaps most strikingly, the researchers identified a behavioral response in their lab animals indicating that the cellular mechanisms driving this structural remodeling can unfold without the compound's hallucinogenic effects, a finding with significant implications for the future design of psychiatric medications. The research team, led by senior author Yi Zuo, professor of molecular, cell, and developmental biology at UC Santa Cruz, set out to observe psilocybin's effects at the microscopic level using two-photon microscopy, a high-resolution imaging technique that allows scientists to peer into the living brain. Over the course of several weeks, the researchers tracked individual dendritic spines, the tiny bulbous protrusions that branch off neurons and act as signal-receiving docks.
These structures form communication bridges called synapses with neighboring neurons, and their formation, maturation, and elimination collectively determine how brain circuits are wired and rewired over time. When psilocybin was administered, the team observed a rapid increase in the formation of new dendritic spines within just 24 hours, providing a direct, real-time window into the structural plasticity the drug induces. Formation alone, however, tells only part of the story.
The researchers found that psilocybin also accelerated the physical maturation of these new connections. In untreated mice, new spines typically begin as immature stubby shapes that remain unstable and short-lived, prone to disappearing before they can contribute meaningfully to circuit function. Under psilocybin treatment, a significantly higher proportion of new spines rapidly grew into large mushroom shapes, which are mature, stable structures equipped with abundant neurotransmitter receptors.
These mushroom spines are capable of holding strong and enduring memory and mood signals, meaning that the connections psilocybin helps create are not merely transient but are structurally prepared to integrate into existing neural circuitry and persist over time, leaving a lasting structural trace of the drug's effects on the brain. Jacob Baker, the study's lead author and a Ph.D. student in Zuo's lab, emphasized the significance of this persistence for understanding how psychedelics produce enduring changes. Psychedelics are fascinating compounds, he noted, because they have the potential to profoundly transform who we are by reshaping the neural circuits in our brains.
The newly formed connections, according to Baker, can integrate into existing neural circuitry and persist over time. The new study approaches a central question in psychedelic research at the cellular level rather than relying solely on behavioral or clinical observations: whether the intense subjective experience itself is necessary for the lasting changes in brain connectivity that these compounds produce. By imaging structural changes directly, the researchers gained a concrete framework for addressing that question.
A key discovery of the study is that psilocybin's impact depends on the brain's prior exposure to chronic stress. In healthy control mice, psilocybin induced a temporary surge in new connection formation, followed by a gradual return toward baseline over three weeks as older connections that existed before treatment were eliminated. This balancing act ensured that the healthy brain maintained structural stability while still updating its circuit wiring, a process the researchers describe as controlled turnover rather than indiscriminate growth.
The finding challenges the simplistic notion that psilocybin simply boosts neural connectivity across the board, and instead suggests that its effects are calibrated to the brain's underlying condition. That calibration became even more apparent when the team examined mice subjected to chronic stress, using an unpredictable mild stress model designed to mimic aspects of human depressive states. Chronic stress is known to degrade synapses and disrupt circuit function, and the stressed brains in this study showed the kinds of structural damage associated with such degradation.
When psilocybin was administered to these animals, the drug's effects diverged sharply from what was seen in healthy mice. In the stressed brains, psilocybin sparked a significantly stronger increase in new spine formation and simultaneously halted the excessive loss of existing connections, effectively counteracting the structural decay that chronic stress had produced. The researchers interpret this as evidence that psilocybin's structural effects are selectively engaged in brains whose circuits have been disrupted by stress.
The most consequential finding, however, concerns the relationship between psilocybin's structural effects and its hallucinogenic properties. To investigate this, the team turned to the serotonin 2A receptor, the molecular docking site on neurons through which psilocybin exerts its effects, focusing on layer 5 pyramidal neurons, a population of principal output cells in the cerebral cortex. Using specialized mouse lines, the researchers selectively restored or removed these receptors within layer 5 pyramidal neurons while leaving the rest of the brain untouched.
When the receptors were restored in these neurons, psilocybin successfully triggered new synapse formation and structural stabilization. Yet these same animals failed to exhibit the head-twitch response, a rapid rotational movement in rodents that serves as a well-established behavioral proxy for hallucinogenic activity. The reverse experiment confirmed the dissociation.
When the researchers deleted serotonin 2A receptors from layer 5 pyramidal neurons, psilocybin could no longer induce new synapse formation in those cells, yet the animals still displayed the head-twitch response at normal levels. This double dissociation demonstrates that the cellular machinery responsible for psilocybin's structural neuroplasticity is separable from the machinery responsible for its hallucinogenic behavioral effects, at least within this specific population of cortical neurons. The finding provides a concrete cellular framework for developing psychedelic-inspired therapeutics that retain the circuit-remodeling benefits of psilocybin while avoiding the perceptual alterations that complicate its clinical use, a goal the researchers describe as a promising direction for future drug design.
The study, published in Nature Neuroscience with support from the National Institutes of Health, arrives at a moment of renewed scientific and clinical interest in psychedelic compounds. By demonstrating that psilocybin's structural and hallucinogenic effects can be experimentally separated in mice, the UC Santa Cruz team has provided a roadmap for future research aimed at isolating the therapeutic components of psychedelic action. The work also underscores the value of high-resolution imaging in living brain tissue, which allowed the researchers to observe structural changes as they unfolded rather than inferring them from postmortem tissue, and it establishes a platform for testing next-generation compounds designed to promote plasticity without hallucinations.
Subject of Research: Neuroscience
Article Title: How psilocybin reshapes brain circuits
Article References: How psilocybin reshapes brain circuits. Original publication (Bibliographic details unavailable.)
Image Credits: AI Generated
DOI: Not provided
Keywords: psilocybin, neuroplasticity, dendritic spines, serotonin 2A receptor, layer 5 pyramidal neurons, chronic stress, depression, psychedelics, two-photon microscopy, Nature Neuroscience, reshapes, brain
News Source: Cassandra Pierce. (October 24, 2026). Psilocybin rewires brain circuits through a pathway separate from hallucinations. Scienmag.
